Enveric Biosciences stock rose 2.3% in premarket trades on Monday after the company said it submitted a confidential form S-1 draft registration statement with the U.S. Securities and Exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback